Brouard; Sophie

Patent Applications and Registrations

Patent applications and USPTO patent grants for Brouard; Sophie.The latest application filed is for "methods and compositions for predicting chronic lung allograft dysfunction".

Company Profile

5.6.16

Brouard; Sophie - Suce-sur-Erdre FR
Brouard; Sophie - Nantes FR
BROUARD; Sophie - Su?e-sur-Erdre FR
Brouard, Sophie - Petit-Mars FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and compositions for predicting chronic lung allograft dysfunction Grant 11,421,277 - Danger , et al. August 23, 2	2022-08-23
Methods And Compositions For Predicting Chronic Lung Allograft Dysfunction App 20210404000 - ROYER; Pierre-Joseph ; et al.	2021-12-30
Methods and Compositions For Predicting Chronic Lung Allograft Dysfunction App 20210139989 - DANGER; Richard ; et al.	2021-05-13
Methods and compositions for predicting chronic lung allograft dysfunction Grant 10,975,438 - Royer , et al. April 13, 2	2021-04-13
Methods for predicting graft alterations Grant 10,961,580 - Brouard , et al. March 30, 2	2021-03-30
Cd24hicd38hi Transitional B Cells And Cd9 As New Biomarker Of Long-term Human Lung Allograft Survivial App 20200057064 - BROSSEAU; Carole ; et al.	2020-02-20
Methods For Discriminating A Tolerant Subject App 20190264281 - Danger; Richard ; et al.	2019-08-29
Methods And Compositions For Predicting Chronic Lung Allograft Dysfunction App 20190226027 - ROYER; Pierre-Joseph ; et al.	2019-07-25
Methods For Predicting Graft Alterations App 20170342494 - Brouard; Sophie ; et al.	2017-11-30
Antibodies directed against the alpha chain of IL7 receptor--their use for the preparation of drug candidates Grant 9,447,182 - Brouard , et al. September 20, 2	2016-09-20
Markers For Long-term Kidney Graft Dysfunction App 20160139122 - DEGAUQUE; Nicolas ; et al.	2016-05-19
Methods and compositions for determining a graft tolerant phenotype in a subject Grant 8,932,808 - Sarwal , et al. January 13, 2	2015-01-13
Antibodies Directed Against The Alpha Chain Of Il7 Receptor - Their Use For The Preparation Of Drug Candidates App 20140308281 - Brouard; Sophie ; et al.	2014-10-16
Methods and Compositions for Determining a Graft Tolerant Phenotype in a Subject App 20140206566 - Sarwal; Minne M. ; et al.	2014-07-24
Detection Of Antigen-specific Peripheral Blood Mononuclear Cells And Methods For Diagnosing Immune Disorders App 20130177925 - Soulillou; Jean Paul ; et al.	2013-07-11
Psmb10: A Diagnosis Marker And Therapeutic Target Of Chronic Rejection App 20110071071 - Brouard; Sophie ; et al.	2011-03-24
Diagnostic Of Immune Graft Tolerance Using Tmtc3 Gene Expression Levels App 20100305038 - Brouard; Sophie ; et al.	2010-12-02
Diagnostic Of Immune Graft Tolerance App 20100304988 - Brouard; Sophie ; et al.	2010-12-02
Methods for Diagnosing and Treating Graft Rejection and Inflammatory Conditions App 20100104581 - Brouard; Sophie ; et al.	2010-04-29
Method for analyzing t lymphocytes with the aid of t lymphocyte receptors of an organism App 20050019764 - Soulillou, Jean-Paul ; et al.	2005-01-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.